Compares arm function and strength in children with hemophilia and healthy children
Compares arm strength and daily activity limits in children with hemophilia and healthy children.
Key facts
- Who runs it
- Hacettepe University
- Where
- Ankara, TürkiyeSee the site
- Trial code
- Registry title
- Comparison of Upper Extremity Functional Performance in Hemophilic and Healthy Children
- Status
- Enrolling by invitation
- People taking part
- 30 people, planned
- Started
- 24 Oct 2024
- Planned end
- 24 Oct 2026
- Type of study
- Observational
- Record updated
- 13 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for boys aged 7 to 17 with hemophilia A or B who get regular preventive treatment. It also takes healthy children for comparison.
- Age
- 7 Years to 17 Years
- Sex
- Male only
- Disease stage
- Hemophilia A or B.
- Earlier treatment
- Must be getting prophylaxis treatment (a routine treatment).
- Biomarker or test result
- Negative for inhibitors at the time of enrollment.
Main reasons for not taking part
- Positive for inhibitors at the time of enrollment
- Acute elbow bleeding
- History of acute muscle bleeding
- History of surgery in any upper extremity joints
- Having undergone radionuclide synovectomy
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Diagnosed with Hemophilia A or B
- Receiving prophylaxis treatment (a routine treatment)
- Negative for inhibitors at the time of enrollment
Who cannot take part
- Positive for inhibitors at the time of enrollment
- Acute elbow bleeding
- History of acute muscle bleeding
- History of surgery in any upper extremity joints
- Having undergone radionuclide synovectomy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 7 and 17 years old?
Where in Türkiye
- Hacettepe UniversitAnkara, TürkiyeNo longer taking part
About the trial
What the trial wants to find out
The goal of this observational study is to evaluate the functional performance of the upper extremity joints (scapula, shoulder, elbow, and wrist) in haemophilic children and compare muscle strength and ADL limitations with healthy children.
The group in the trial
- Hemophilia groups
Patients group
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Comparison of Upper Extremity Functional Performance, Muscle Strength, and Activities of Daily Living Levels in Children with Hemophilia and Healthy Children
- Plain-language title
- Compares arm function and strength in children with hemophilia and healthy childrenGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06826209, who can take part
- Record updated
- 13 February 2025